Literature DB >> 19937373

Cardiac resynchronization therapy is effective even in elderly patients with comorbidities.

Natália António1, Carolina Lourenço, Rogério Teixeira, Fátima Saraiva, Lourenço Coelho, Miguel Ventura, João Cristóvão, Luís Elvas, Lino Gonçalves, Luís A Providência.   

Abstract

PURPOSE: The purpose of this study was to compare the effects of cardiac resynchronization therapy (CRT) in elderly patients (> or =65 years) with younger patients and to assess the impact of comorbidities in CRT remodeling response.
METHODS: This is a prospective study of 87 consecutive patients scheduled for CRT who underwent clinical and echocardiographic evaluation before and 6 months after CRT. A reduction in left ventricular end-systolic volume (LVESV) > or =15% after CRT defined remodeling responders, and a reduction of at least one New York Heart Association class defined clinical responders. Multivariate analysis was used to identify independent predictors of non-response to CRT in terms of reverse remodeling.
RESULTS: The mean age was 62 +/- 11 years, with 36 elderly patients (41%). The baseline QRS duration was 145 +/- 32 ms. After CRT, there were significant and similar improvements of left ventricular (LV) ejection fraction, LVESV, LV dP/dt, and mitral regurgitation jet area (JA) between elderly (> or =65 years) and younger (<65 years) patients. The number of clinical and remodeling responders was comparable, and we found no significant differences in unplanned cardiac hospitalizations at 6 months between groups. Independent predictors of lack of remodeling response to CRT were QRS duration <120 ms, LV diastolic diameter >74 mm, and JA >10 cm(2) before CRT, but not comorbidities.
CONCLUSION: This work suggests that being elderly is not an impediment to CRT success even in the presence of comorbidities.

Entities:  

Mesh:

Year:  2009        PMID: 19937373     DOI: 10.1007/s10840-009-9449-9

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  35 in total

1.  Spectrum of heart failure in older patients: results from the National Heart Failure project.

Authors:  Edward P Havranek; Frederick A Masoudi; Kelly A Westfall; Pam Wolfe; Diana L Ordin; Harlan M Krumholz
Journal:  Am Heart J       Date:  2002-03       Impact factor: 4.749

2.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

3.  Clinical response of cardiac resynchronization therapy in the elderly.

Authors:  Peter Paul H M Delnoy; Jan Paul Ottervanger; Henk Oude Luttikhuis; Arif Elvan; Anand R Ramdat Misier; Willem P Beukema; Norbert M van Hemel
Journal:  Am Heart J       Date:  2008-02-21       Impact factor: 4.749

4.  Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial.

Authors:  Mariantonietta Cicoira; Aldo Pietro Maggioni; Roberto Latini; Simona Barlera; Elisa Carretta; Andras Janosi; Jordi Soler Soler; Inder Anand; Jay N Cohn
Journal:  Eur J Heart Fail       Date:  2006-12-12       Impact factor: 15.534

5.  Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.

Authors:  Jalal K Ghali; John Boehmer; Arthur M Feldman; Leslie A Saxon; Teresa Demarco; Peter Carson; Patrick Yong; Elizabeth G Galle; Jill Leigh; Fred L Ecklund; Michael R Bristow
Journal:  J Card Fail       Date:  2007-11       Impact factor: 5.712

6.  Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.

Authors:  John F Beshai; Richard A Grimm; Sherif F Nagueh; James H Baker; Scott L Beau; Steven M Greenberg; Luis A Pires; Patrick J Tchou
Journal:  N Engl J Med       Date:  2007-11-06       Impact factor: 91.245

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

8.  Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population.

Authors:  Paul W X Foley; Shajil Chalil; Kayvan Khadjooi; Russell E A Smith; Michael P Frenneaux; Francisco Leyva
Journal:  Europace       Date:  2008-09-30       Impact factor: 5.214

9.  Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy.

Authors:  Cecilia Fantoni; François Regoli; Ali Ghanem; Santi Raffa; Catherine Klersy; Antonio Sorgente; Francesco Faletra; Massimo Baravelli; Luigi Inglese; Jorge A Salerno-Uriarte; Helmut U Klein; Tiziano Moccetti; Angelo Auricchio
Journal:  Eur J Heart Fail       Date:  2008-03-04       Impact factor: 15.534

Review 10.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

View more
  4 in total

1.  Comparison of pharmacological treatment alone versus treatment combined with cardiac resynchronization therapy in patients over 75 years.

Authors:  Elena de la Cruz; Marcelino Cortés; Jerónimo Farré; Julia Palfy; Paloma Ávila; Ignacio Hernández; Angélica Romero; Juan Benezet; Juan Antonio Franco; Miguel Angel Navas; Jose Joel Hernandez; Sem Briongos; José M Rubio
Journal:  J Interv Card Electrophysiol       Date:  2015-02-17       Impact factor: 1.900

Review 2.  Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Authors:  Naomi D Herz; Joseph Engeda; Robbert Zusterzeel; William E Sanders; Kathryn M O'Callaghan; David G Strauss; Samantha B Jacobs; Kimberly A Selzman; Ileana L Piña; Daniel A Caños
Journal:  J Womens Health (Larchmt)       Date:  2015-03-20       Impact factor: 2.681

Review 3.  Co-Morbidities and Cardiac Resynchronization Therapy: When Should They Modify Patient Selection?

Authors:  Martin H Ruwald
Journal:  J Atr Fibrillation       Date:  2015-06-30

4.  Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy.

Authors:  Luiz Eduardo Montenegro Camanho; Eduardo Benchimol Saad; Charles Slater; Luiz Antonio Oliveira Inacio Junior; Gustavo Vignoli; Lucas Carvalho Dias; Pedro Pimenta de Mello Spineti; Ricardo Mourilhe-Rocha
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.